Tarantini, M.G.; Ramos, S.; Secrétan, P.-H.; Guichard, L.; Hassani, L.; Bellanger, A.; Mayaux, J.; Tilleul, P.; El Kouari, F.; Sadou Yayé, H.
Therapeutic Treatment Plan Optimization during the COVID-19 Pandemic: A Comprehensive Physicochemical Compatibility Study of Intensive Care Units Selected Drugs. Pharmaceutics 2022, 14, 550.
https://doi.org/10.3390/pharmaceutics14030550
AMA Style
Tarantini MG, Ramos S, Secrétan P-H, Guichard L, Hassani L, Bellanger A, Mayaux J, Tilleul P, El Kouari F, Sadou Yayé H.
Therapeutic Treatment Plan Optimization during the COVID-19 Pandemic: A Comprehensive Physicochemical Compatibility Study of Intensive Care Units Selected Drugs. Pharmaceutics. 2022; 14(3):550.
https://doi.org/10.3390/pharmaceutics14030550
Chicago/Turabian Style
Tarantini, Maria Gloria, Stéphanie Ramos, Philippe-Henri Secrétan, Laura Guichard, Lamia Hassani, Agnès Bellanger, Julien Mayaux, Patrick Tilleul, Fadwa El Kouari, and Hassane Sadou Yayé.
2022. "Therapeutic Treatment Plan Optimization during the COVID-19 Pandemic: A Comprehensive Physicochemical Compatibility Study of Intensive Care Units Selected Drugs" Pharmaceutics 14, no. 3: 550.
https://doi.org/10.3390/pharmaceutics14030550
APA Style
Tarantini, M. G., Ramos, S., Secrétan, P. -H., Guichard, L., Hassani, L., Bellanger, A., Mayaux, J., Tilleul, P., El Kouari, F., & Sadou Yayé, H.
(2022). Therapeutic Treatment Plan Optimization during the COVID-19 Pandemic: A Comprehensive Physicochemical Compatibility Study of Intensive Care Units Selected Drugs. Pharmaceutics, 14(3), 550.
https://doi.org/10.3390/pharmaceutics14030550